Korean Circ J.  2023 Sep;53(9):648-649. 10.4070/kcj.2023.0199.

Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt

• Dell’Angela L
• Nicolosi GL

• KMID: 2545960
• DOI: http://doi.org/10.4070/kcj.2023.0199

Reference

1. Lee OH, Kim JS. Percutaneous patent foramen ovale closure after stroke. Korean Circ J. 2022; 52:801–807. PMID: 36347516.

2. Dell’Angela L, Nicolosi GL. Patent foramen ovale closure after cryptogenic stroke: sometimes uncertain benefit maybe, or even potential harm in the long run? J Cardiovasc Med (Hagerstown). 2023; 24:381–391. PMID: 37161975.

3. Kolokathis K, Thomopoulos C, Tsioufis K. Net clinical benefit of PFO closure versus medical treatment in patients with cryptogenic stroke: a systematic review and meta-analysis. Hellenic J Cardiol. 2023; 70:46–52. PMID: 36584788.

4. Pristipino C, Sievert H, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019; 40:3182–3195. PMID: 30358849.